The malaria testing and treatment landscape in mainland Tanzania, 2016

Malaria Journal
ACTwatch GroupSigsbert Patila Mkunde

Abstract

Understanding the key characteristics of malaria testing and treatment is essential to the control of a disease that continues to pose a major risk of morbidity and mortality in mainland Tanzania, with evidence of a resurgence of the disease in recent years. The introduction of artemisinin combination therapy (ACT) as the first-line treatment for malaria, alongside policies to promote rational case management following testing, highlights the need for evidence of anti-malarial and testing markets in the country. The results of the most recent mainland Tanzania ACTwatch outlet survey are presented here, including data on the availability, market share and price of anti-malarials and malaria diagnosis in 2016. A nationally-representative malaria outlet survey was conducted between 18th May and 2nd July, 2016. A census of public and private outlets with potential to distribute malaria testing and/or treatment was conducted among a representative sample of administrative units. An audit was completed for all anti-malarials, malaria rapid (RDT) diagnostic tests and microscopy. A total of 5867 outlets were included in the nationally representative survey, across both public and private sectors. In the public sector, availability of m...Continue Reading

References

Nov 2, 2011·Malaria Journal·Tanya ShewchukDesmond Chavasse
Jun 14, 2012·International Journal for Equity in Health·Marinka van der HoevenMinrie Greeff
Feb 7, 2013·Malaria Journal·Kathryn A O'ConnellCatherine Goodman
Feb 19, 2013·Trends in Parasitology·V Bhargavi RaoAzra C Ghani
Sep 17, 2013·Drug, Healthcare and Patient Safety·Appolinary Ar Kamuhabwa, Richard Silumbe
Sep 12, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·UNKNOWN ESMO/European Sarcoma Network Working Group

❮ Previous
Next ❯

Citations

Jun 4, 2019·PloS One·Marceline F FindaFredros O Okumu
Nov 28, 2019·Malaria Journal·Billy Ngasala, Samweli Bushukatale

❮ Previous
Next ❯

Software Mentioned

ACTwatch
DroidDB
Stata

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.